FDA Inspection 1043371 - Gland Pharma Limited, Units I+II Pashamylaram Site - February 23, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on February 23, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date: February 23, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 2a89c877-04b5-44c9-bda9-2d69a6bcbb57

Violation Codes4

21 CFR 211.110(b)21 CFR 211.113(b)21 CFR 211.198(a)21 CFR 211.25(a)

Full citation text and observation details available on the Dashboard.